1. Home
  2. EML vs TVGN Comparison

EML vs TVGN Comparison

Compare EML & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

HOLD

Current Price

$24.91

Market Cap

152.9M

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$7.31

Market Cap

21.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EML
TVGN
Founded
1858
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
21.3M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
EML
TVGN
Price
$24.91
$7.31
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
9.6K
6.5K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
N/A
EPS
1.04
N/A
Revenue
$248,970,345.00
N/A
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.95
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$0.14
52 Week High
$29.91
$12.03

Technical Indicators

Market Signals
Indicator
EML
TVGN
Relative Strength Index (RSI) 42.81 67.37
Support Level $24.10 $6.22
Resistance Level $27.16 $7.90
Average True Range (ATR) 1.36 0.41
MACD -0.25 0.04
Stochastic Oscillator 16.23 88.98

Price Performance

Historical Comparison
EML
TVGN

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: